YOLFTbeta
30

Tianjin Ringpu Bio Tech

300119 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

16.41CNY-0.07 (-0.42%)

Price History

Full chart

Market Stats

Previous Close16.48
Open16.50
Day Range16.38 – 16.79
52-Week Range13.91 – 22.44
Volume3.21M
Market Cap7.79B
P/E (TTM)21.77
Forward P/E10.76
EPS0.77
Dividend Yield2.39%
Beta0.12
50-Day Avg17.46
200-Day Avg17.84

About

Tianjin Ringpu Bio-Technology Co.,Ltd. engages in the research and development, production, and sale of veterinary raw materials, pharmaceutical preparation, functional additives, and veterinary biological products. The company provides vaccines, chemical drugs, traditional Chinese medicines; feed additives, including pigs, chickens, waterfowl, cattle, sheep and pet medicines, and vaccines; and poultry, waterfowl, livestock, rumination, pets, washing and disinfection, active pharmaceutical ingredients product series. It also offers diagnosis and treatment services, such as epidemic diagnosis and testing, animal drug evaluation, and veterinary socialization. The company was founded in 1998 and is headquartered in Tianjin, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Lei Xu
  • Employees2.80K
  • HeadquartersNo. 1, East 9th Road, Tianjin, China, 300308, China
  • Websitehttps://www.ringpu.com

Leadership

  • Mr. Lei XuGM & Director · b. 1973
  • Ms. Gaibian LiFinancial Manager · b. 1975
  • Ms. Ailing LiuDeputy GM & Director · b. 1975
  • Mr. Xiutong ZhuNon-Independent Director & Deputy GM · b. 1981
  • Mr. Gang XieBoard Secretary · b. 1985
  • Cai Xia WangHead of Accounting Department

Financials

Income Statement

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue146.10M224.13M285.36M345.62M587.71M656.39M754.90M585.20M792.83M969.86M1.05B1.19B1.47B2.00B2.01B2.08B2.71B3.07B3.40B
Growth (%)-+53.41%+27.31%+21.12%+70.05%+11.69%+15.01%-22.48%+35.48%+22.33%+7.99%+13.61%+23.26%+36.40%+0.34%+3.84%+29.98%+13.32%+10.70%
Cost of Revenue47.47M59.01M64.82M100.75M260.43M273.26M306.88M237.12M327.19M413.61M492.10M593.87M700.37M920.78M969.26M1.07B1.53B1.82B2.00B
Gross Profit98.63M165.12M220.53M244.87M327.29M383.13M448.02M348.08M465.64M556.25M555.23M596.00M766.21M1.08B1.04B1.01B1.18B1.25B1.40B
Gross Margin67.51%73.67%77.28%70.85%55.69%58.37%59.35%59.48%58.73%57.35%53.01%50.09%52.24%53.97%51.71%48.44%43.65%40.71%41.28%
Operating Expense43.86M92.95M120.65M141.08M183.62M223.85M311.67M327.52M340.36M406.70M413.16M434.30M503.14M566.50M538.51M592.90M612.68M876.70M960.99M
Operating Income54.77M72.17M99.88M103.78M143.66M159.28M136.36M20.56M125.28M149.54M142.08M161.70M263.07M513.12M499.36M416.64M569.75M373.17M441.81M
Operating Margin37.49%32.20%35.00%30.03%24.44%24.27%18.06%3.51%15.80%15.42%13.57%13.59%17.94%25.65%24.88%19.99%21.03%12.16%13.00%
EBITDA59.82M78.88M109.51M133.72M173.80M209.56M215.34M82.08M196.65M266.08M250.85M271.35M376.26M634.38M596.07M550.22M736.66M593.63M729.46M
EBITDA Margin40.94%35.19%38.38%38.69%29.57%31.93%28.52%14.03%24.80%27.43%23.95%22.81%25.66%31.71%29.70%26.40%27.19%19.34%21.46%
Net Income36.96M43.32M61.50M82.54M114.09M144.08M151.96M26.99M110.31M132.78M104.90M118.98M194.36M398.20M412.78M346.70M453.59M300.72M400.51M
Net Income Margin25.30%19.33%21.55%23.88%19.41%21.95%20.13%4.61%13.91%13.69%10.02%10.00%13.25%19.91%20.57%16.63%16.74%9.80%11.79%
R&D1.71M3.55M-14.94M20.10M23.90M36.49M37.94M43.89M76.56M85.30M80.33M94.79M111.53M117.69M132.68M172.94M206.65M253.02M
R&D as % of Total Revenue1.17%1.58%-4.32%3.42%3.64%4.83%6.48%5.54%7.89%8.14%6.75%6.46%5.58%5.86%6.37%6.38%6.73%7.45%
Interest Expense132.89K019.21K2.82M2.28M2.68M2.27M2.25M5.03M10.43M15.89M17.65M25.06M27.72M24.31M28.96M26.72M32.95M35.16M
Interest Expense % of Total Revenue0.09%0.00%0.01%0.82%0.39%0.41%0.30%0.38%0.63%1.08%1.52%1.48%1.71%1.39%1.21%1.39%0.99%1.07%1.03%

Balance Sheet

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets186.46M335.15M415.11M1.62B1.67B1.79B2.00B1.98B2.35B2.73B2.92B3.00B3.56B3.90B5.69B6.11B6.60B7.97B7.66B
Total Liabilities50.26M85.18M162.63M195.66M175.12M206.99M282.89M257.23M579.77M627.74M747.95M744.03M1.21B1.16B1.37B1.61B1.79B2.96B2.47B
Total Equity99.33M197.24M206.40M1.35B1.39B1.48B1.61B1.61B1.61B1.90B1.95B2.01B2.12B2.46B4.03B4.22B4.50B4.47B4.70B
Cash47.45M114.80M118.37M1.18B896.73M702.29M510.76M411.88M268.29M295.05M397.80M287.94M396.35M294.47M1.31B384.42M335.40M487.37M651.19M
Total Debt7.00M10.00M35.00M82.00M35.00M31.00M23.00M25.00M127.00M254.88M388.23M353.63M638.08M560.56M738.99M877.68M872.07M1.32B-
Net Debt-40.45M-104.80M-83.37M-1.10B-861.73M-671.29M-487.76M-386.88M-141.29M-40.16M-9.57M65.69M241.73M266.09M-571.12M493.26M536.67M832.48M502.83M

Cash Flow

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow19.15M68.07M64.59M112.82M90.29M89.92M88.68M128.37M225.27M207.67M107.57M174.88M383.61M388.44M382.63M389.49M378.20M735.55M297.53M
Investing Cash Flow-16.87M-52.29M-35.82M-121.28M-203.35M-257.38M-354.10M-102.69M-552.28M-449.98M-58.32M-145.41M-397.76M-243.07M-627.06M-1.24B-160.97M-451.67M-
Financing Cash Flow16.95M51.58M-25.20M1.07B-173.25M-28.50M-26.87M-27.20M47.69M294.65M76.92M-125.93M92.63M-169.86M1.26B-48.35M-272.46M-133.28M-
Capital Expenditure16.99M19.66M31.34M47.79M184.82M167.37M251.60M183.11M151.10M128.13M108.87M112.45M229.70M259.17M305.88M372.43M244.48M185.34M176.10M
Free Cash Flow2.15M48.42M33.25M65.03M-94.53M-77.45M-162.92M-54.74M74.17M79.54M-1.30M62.43M153.91M129.27M76.75M17.05M133.71M550.21M121.43M
Dividends Paid353.99K218.82K50.20M1.27M76.36M47.18M50.35M40.52M43.47M70.00M75.10M80.27M60.67M100.06M160.09M163.69M162.82M215.78M167.50M
FCF to OCF11.24%71.12%51.48%57.64%-104.70%-86.14%-183.71%-42.64%32.92%38.30%-1.21%35.70%40.12%33.28%20.06%4.38%35.36%74.80%40.81%
Dividend Paid to FCF16.45%0.45%150.97%1.95%-80.78%-60.92%-30.90%-74.04%58.62%88.01%-5789.65%128.58%39.42%77.40%208.57%959.93%121.77%39.22%137.94%

Earnings

Report DateSep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Aug 23, 2014Oct 23, 2014Mar 1, 2015Apr 23, 2015Aug 24, 2015Oct 23, 2015Feb 25, 2016Apr 26, 2016Aug 25, 2016Oct 24, 2016Apr 26, 2017Aug 24, 2017Oct 26, 2017Feb 26, 2018Apr 20, 2018Aug 27, 2018Oct 25, 2018Feb 26, 2019Apr 24, 2019Aug 30, 2019Oct 28, 2019Feb 25, 2020Apr 23, 2020Aug 26, 2020Oct 28, 2020Mar 1, 2021Apr 28, 2021Aug 26, 2021Oct 26, 2021Mar 25, 2022Apr 28, 2022Aug 25, 2022Oct 25, 2022Mar 31, 2023Apr 26, 2023Aug 25, 2023Oct 25, 2023Mar 29, 2024Apr 25, 2024Aug 24, 2024Oct 29, 2024Apr 2, 2025Aug 26, 2025Oct 25, 2025Apr 28, 2026Aug 26, 2026
EPS Estimate------------------------------------------------0.370.230.210.28---------
EPS Actual0.070.070.060.090.070.080.060.110.070.140.080.100.070.140.050.030.02-0.030.070.060.080.080.060.070.120.080.060.110.010.100.070.090.030.110.110.150.120.190.190.260.360.290.220.220.290.160.150.200.250.170.210.210.390.190.160.180.120.310.230.240.21
Surprise-------------------------------------------------32.43%-26.09%0.00%-25.00%---------
Timing---------------Pre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hours-Pre-marketPre-market----

Key Statistics & Ratios

Market Cap7.79B
Enterprise Value8.03B
Trailing P/E21.77
Forward P/E10.76
PEG Ratio0.00
Price / Sales2.28
Price / Book1.69
EPS0.77
Book Value10.37
Revenue (TTM)3.41B
Gross Profit (TTM)1.36B
EBITDA571.60M
Profit Margin10.20%
Operating Margin12.67%
Return on Equity7.53%
Return on Assets2.90%
Shares Outstanding464.75M
Shares Float233.30M
Beta0.12
Dividend Yield2.39%
Dividend Rate0.40
Payout Ratio58.61%

Dividends

20261×
0.40May 13, 2026
20251×
0.30May 21, 2025
20241×
0.40May 15, 2024
20231×
0.30Jun 8, 2023
20221×
0.35Jun 13, 2022
20211×
0.40Apr 22, 2021
20201×
0.25May 7, 2020
20191×
0.15May 24, 2019
20181×
0.15May 23, 2018
20171×
0.15May 25, 2017
20161×
0.15May 24, 2016
20151×
0.10May 22, 2015
20141×
0.10Apr 22, 2014
20131×
0.13May 9, 2013
20121×
0.15May 4, 2012
20111×
0.19Apr 25, 2011

Stock Splits

  • Apr 22, 201419.9358:10
  • May 4, 201213:10
  • Apr 25, 201120:10